Alpha-synuclein and the Parkinson's disease-related mutant Ala53Thr-alpha-synuclein do not undergo proteasomal degradation in HEK293 and neuronal cells.
Identifieur interne : 003888 ( Main/Exploration ); précédent : 003887; suivant : 003889Alpha-synuclein and the Parkinson's disease-related mutant Ala53Thr-alpha-synuclein do not undergo proteasomal degradation in HEK293 and neuronal cells.
Auteurs : K. Ancolio [France] ; C. Alves Da Costa ; K. Uéda ; F. CheclerSource :
- Neuroscience letters [ 0304-3940 ] ; 2000.
English descriptors
- KwdEn :
- Alanine (genetics), Amino Acid Substitution (genetics), Animals, Cell Line, Cysteine Endopeptidases (metabolism), Humans, Mice, Multienzyme Complexes (metabolism), Mutation (genetics), Nerve Tissue Proteins (genetics), Nerve Tissue Proteins (metabolism), Neurons (enzymology), Neurons (metabolism), Parkinson Disease (enzymology), Parkinson Disease (genetics), Parkinson Disease (metabolism), Proteasome Endopeptidase Complex, Synucleins, Threonine (genetics), Transfection, alpha-Synuclein.
- MESH :
- chemical , genetics : Alanine, Nerve Tissue Proteins, Threonine.
- enzymology : Neurons, Parkinson Disease.
- genetics : Amino Acid Substitution, Mutation, Parkinson Disease.
- chemical , metabolism : Cysteine Endopeptidases, Multienzyme Complexes, Nerve Tissue Proteins, Neurons, Parkinson Disease.
- Animals, Cell Line, Humans, Mice, Proteasome Endopeptidase Complex, Synucleins, Transfection, alpha-Synuclein.
Abstract
Synucleins are neuronal proteins detectable in the neuropathological lesions of several cerebral disorders. Thus, alpha-synuclein immunoreactivity is found in Lewy bodies, the histopathological hallmark of sporadic Parkinson disease-affected brains. When mutated, alpha-synuclein seems to be responsible for some familial forms of Parkinson disease. As Lewy bodies are enriched in ubiquitinated structures and also contain proteasome-related immunoreactivity, it could be hypothesized that the proteasome contributes to the cellular degradation of alpha-synucleins, thereby controlling their concentration-dependent aggregation process. Here, we first demonstrate that alpha-synuclein is not ubiquitinated in HEK293 cells. Furthermore, by means of two specific inhibitors, we show that wild type and Ala53Thr alpha-synuclein do not behave as proteasome substrates in HEK293 cells and murine neurons. Our study indicates that the proteasome does not contribute to the control of cellular synucleins concentration and therefore, unlikely participates to cerebral alpha-synucleinopathies.
PubMed: 10793231
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 001314
- to stream PubMed, to step Curation: 001273
- to stream PubMed, to step Checkpoint: 001273
- to stream Ncbi, to step Merge: 000111
- to stream Ncbi, to step Curation: 000111
- to stream Ncbi, to step Checkpoint: 000111
- to stream Main, to step Merge: 003F34
- to stream Main, to step Curation: 003888
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Alpha-synuclein and the Parkinson's disease-related mutant Ala53Thr-alpha-synuclein do not undergo proteasomal degradation in HEK293 and neuronal cells.</title>
<author><name sortKey="Ancolio, K" sort="Ancolio, K" uniqKey="Ancolio K" first="K" last="Ancolio">K. Ancolio</name>
<affiliation wicri:level="3"><nlm:affiliation>Institut de Pharmacologie Moléculaire et Cellulaire du CNRS, UPR411, 660 Route des Lucioles, Sophia Antipolis, 06560, Valbonne, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Institut de Pharmacologie Moléculaire et Cellulaire du CNRS, UPR411, 660 Route des Lucioles, Sophia Antipolis, 06560, Valbonne</wicri:regionArea>
<placeName><region type="region" nuts="2">Provence-Alpes-Côte d'Azur</region>
<settlement type="city">Valbonne</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Alves Da Costa, C" sort="Alves Da Costa, C" uniqKey="Alves Da Costa C" first="C" last="Alves Da Costa">C. Alves Da Costa</name>
</author>
<author><name sortKey="Ueda, K" sort="Ueda, K" uniqKey="Ueda K" first="K" last="Uéda">K. Uéda</name>
</author>
<author><name sortKey="Checler, F" sort="Checler, F" uniqKey="Checler F" first="F" last="Checler">F. Checler</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2000">2000</date>
<idno type="RBID">pubmed:10793231</idno>
<idno type="pmid">10793231</idno>
<idno type="wicri:Area/PubMed/Corpus">001314</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001314</idno>
<idno type="wicri:Area/PubMed/Curation">001273</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001273</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001273</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001273</idno>
<idno type="wicri:Area/Ncbi/Merge">000111</idno>
<idno type="wicri:Area/Ncbi/Curation">000111</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000111</idno>
<idno type="wicri:doubleKey">0304-3940:2000:Ancolio K:alpha:synuclein:and</idno>
<idno type="wicri:Area/Main/Merge">003F34</idno>
<idno type="wicri:Area/Main/Curation">003888</idno>
<idno type="wicri:Area/Main/Exploration">003888</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Alpha-synuclein and the Parkinson's disease-related mutant Ala53Thr-alpha-synuclein do not undergo proteasomal degradation in HEK293 and neuronal cells.</title>
<author><name sortKey="Ancolio, K" sort="Ancolio, K" uniqKey="Ancolio K" first="K" last="Ancolio">K. Ancolio</name>
<affiliation wicri:level="3"><nlm:affiliation>Institut de Pharmacologie Moléculaire et Cellulaire du CNRS, UPR411, 660 Route des Lucioles, Sophia Antipolis, 06560, Valbonne, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Institut de Pharmacologie Moléculaire et Cellulaire du CNRS, UPR411, 660 Route des Lucioles, Sophia Antipolis, 06560, Valbonne</wicri:regionArea>
<placeName><region type="region" nuts="2">Provence-Alpes-Côte d'Azur</region>
<settlement type="city">Valbonne</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Alves Da Costa, C" sort="Alves Da Costa, C" uniqKey="Alves Da Costa C" first="C" last="Alves Da Costa">C. Alves Da Costa</name>
</author>
<author><name sortKey="Ueda, K" sort="Ueda, K" uniqKey="Ueda K" first="K" last="Uéda">K. Uéda</name>
</author>
<author><name sortKey="Checler, F" sort="Checler, F" uniqKey="Checler F" first="F" last="Checler">F. Checler</name>
</author>
</analytic>
<series><title level="j">Neuroscience letters</title>
<idno type="ISSN">0304-3940</idno>
<imprint><date when="2000" type="published">2000</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Alanine (genetics)</term>
<term>Amino Acid Substitution (genetics)</term>
<term>Animals</term>
<term>Cell Line</term>
<term>Cysteine Endopeptidases (metabolism)</term>
<term>Humans</term>
<term>Mice</term>
<term>Multienzyme Complexes (metabolism)</term>
<term>Mutation (genetics)</term>
<term>Nerve Tissue Proteins (genetics)</term>
<term>Nerve Tissue Proteins (metabolism)</term>
<term>Neurons (enzymology)</term>
<term>Neurons (metabolism)</term>
<term>Parkinson Disease (enzymology)</term>
<term>Parkinson Disease (genetics)</term>
<term>Parkinson Disease (metabolism)</term>
<term>Proteasome Endopeptidase Complex</term>
<term>Synucleins</term>
<term>Threonine (genetics)</term>
<term>Transfection</term>
<term>alpha-Synuclein</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en"><term>Alanine</term>
<term>Nerve Tissue Proteins</term>
<term>Threonine</term>
</keywords>
<keywords scheme="MESH" qualifier="enzymology" xml:lang="en"><term>Neurons</term>
<term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>Amino Acid Substitution</term>
<term>Mutation</term>
<term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>Cysteine Endopeptidases</term>
<term>Multienzyme Complexes</term>
<term>Nerve Tissue Proteins</term>
<term>Neurons</term>
<term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Animals</term>
<term>Cell Line</term>
<term>Humans</term>
<term>Mice</term>
<term>Proteasome Endopeptidase Complex</term>
<term>Synucleins</term>
<term>Transfection</term>
<term>alpha-Synuclein</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Synucleins are neuronal proteins detectable in the neuropathological lesions of several cerebral disorders. Thus, alpha-synuclein immunoreactivity is found in Lewy bodies, the histopathological hallmark of sporadic Parkinson disease-affected brains. When mutated, alpha-synuclein seems to be responsible for some familial forms of Parkinson disease. As Lewy bodies are enriched in ubiquitinated structures and also contain proteasome-related immunoreactivity, it could be hypothesized that the proteasome contributes to the cellular degradation of alpha-synucleins, thereby controlling their concentration-dependent aggregation process. Here, we first demonstrate that alpha-synuclein is not ubiquitinated in HEK293 cells. Furthermore, by means of two specific inhibitors, we show that wild type and Ala53Thr alpha-synuclein do not behave as proteasome substrates in HEK293 cells and murine neurons. Our study indicates that the proteasome does not contribute to the control of cellular synucleins concentration and therefore, unlikely participates to cerebral alpha-synucleinopathies.</div>
</front>
</TEI>
<affiliations><list><country><li>France</li>
</country>
<region><li>Provence-Alpes-Côte d'Azur</li>
</region>
<settlement><li>Valbonne</li>
</settlement>
</list>
<tree><noCountry><name sortKey="Alves Da Costa, C" sort="Alves Da Costa, C" uniqKey="Alves Da Costa C" first="C" last="Alves Da Costa">C. Alves Da Costa</name>
<name sortKey="Checler, F" sort="Checler, F" uniqKey="Checler F" first="F" last="Checler">F. Checler</name>
<name sortKey="Ueda, K" sort="Ueda, K" uniqKey="Ueda K" first="K" last="Uéda">K. Uéda</name>
</noCountry>
<country name="France"><region name="Provence-Alpes-Côte d'Azur"><name sortKey="Ancolio, K" sort="Ancolio, K" uniqKey="Ancolio K" first="K" last="Ancolio">K. Ancolio</name>
</region>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003888 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003888 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= ParkinsonFranceV1 |flux= Main |étape= Exploration |type= RBID |clé= pubmed:10793231 |texte= Alpha-synuclein and the Parkinson's disease-related mutant Ala53Thr-alpha-synuclein do not undergo proteasomal degradation in HEK293 and neuronal cells. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:10793231" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \ | NlmPubMed2Wicri -a ParkinsonFranceV1
This area was generated with Dilib version V0.6.29. |